Your session is about to expire
← Back to Search
Virtually Administered Cardiac Rehab Program for Heart Failure (VIRT-CR Trial)
N/A
Waitlist Available
Led By Srinath Adusumalli, MD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who have been prescribed cardiac rehabilitation as part of their standard of care
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up labs will be collected up to 27 months post study enrollment
Awards & highlights
VIRT-CR Trial Summary
This trial is testing whether a home-based cardiac rehab program with real-time, video-based exercise supervision and vitals monitoring is effective.
Who is the study for?
This trial is for heart failure patients who've been prescribed cardiac rehab. Participants need to have an email and cell phone, be able to exercise at home, and not have severe exercise limitations or active cancer treatment.Check my eligibility
What is being tested?
The study compares a virtual cardiac rehab program with real-time video supervision against the standard in-person approach. It aims to see if patients can effectively perform rehab at home with remote guidance.See study design
What are the potential side effects?
Since this trial involves exercise as part of cardiac rehabilitation, potential side effects may include muscle soreness, fatigue, and in rare cases, cardiovascular events due to exertion.
VIRT-CR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been prescribed cardiac rehabilitation.
VIRT-CR Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ labs will be collected up to 27 months post study enrollment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~labs will be collected up to 27 months post study enrollment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in VO2 max (ml/kg/min)
Secondary outcome measures
Attendance
Blood Pressure
Change in HDL
+5 moreVIRT-CR Trial Design
2Treatment groups
Active Control
Group I: InterventionActive Control1 Intervention
Virtual cardiac rehab program delivered through the CardaHealth platform.
Group II: ControlActive Control1 Intervention
Clinically ordered standard of care cardiac rehab program (in-person).
Find a Location
Who is running the clinical trial?
Independence Blue CrossUNKNOWN
6 Previous Clinical Trials
126,312 Total Patients Enrolled
1 Trials studying Heart Failure
700 Patients Enrolled for Heart Failure
University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,863 Total Patients Enrolled
42 Trials studying Heart Failure
7,289 Patients Enrolled for Heart Failure
CardaHealthUNKNOWN
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many participants have joined the trial to date?
"Affirmative. Clinicaltrials.gov data reveals that this research, which was initially made available on December 8th 2021, is currently looking for participants. 225 subjects need to be enrolled from a single site."
Answered by AI
Are there any vacancies for participation in this clinical trial?
"According to clinicaltrials.gov, this trial is currently enrolling participants after first being posted on December 8th 2021 and concluding its most recent update on May 16th 2022."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger